Let’s start up with the current stock price of Opiant Pharmaceuticals Inc. (OPNT), which is $12.00 to be very precise. The Stock rose vividly during the last session to $17.53 after opening rate of $17.51 while the lowest price it went was recorded $11.08 before closing at $18.35.Recently in News on May 10, 2022, Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update. Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three months ended March 31, 2022, and provided a corporate update. Recent highlights include:. You can read further details here
Opiant Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $33.95 on 01/03/22, with the lowest value was $11.08 for the same time period, recorded on 05/11/22.
Opiant Pharmaceuticals Inc. (OPNT) full year performance was -4.08%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Opiant Pharmaceuticals Inc. shares are logging -68.18% during the 52-week period from high price, and 0.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.00 and $37.71.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 561902 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Opiant Pharmaceuticals Inc. (OPNT) recorded performance in the market was -64.32%, having the revenues showcasing -52.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 60.60M, as it employees total of 30 workers.
The Analysts eye on Opiant Pharmaceuticals Inc. (OPNT)
During the last month, 0 analysts gave the Opiant Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 25.56, with a change in the price was noted -21.06. In a similar fashion, Opiant Pharmaceuticals Inc. posted a movement of -63.70% for the period of last 100 days, recording 83,605 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OPNT is recording 0.45 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.45.
Technical rundown of Opiant Pharmaceuticals Inc. (OPNT)
Raw Stochastic average of Opiant Pharmaceuticals Inc. in the period of last 50 days is set at 5.06%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.86%. In the last 20 days, the company’s Stochastic %K was 6.43% and its Stochastic %D was recorded 10.80%.
Considering, the past performance of Opiant Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -64.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -56.60%, alongside a downfall of -4.08% for the period of the last 12 months. The shares increased approximately by -39.27% in the 7-day charts and went down by -38.74% in the period of the last 30 days. Common stock shares were lifted by -52.48% during last recorded quarter.